Filing Details
- Accession Number:
- 0001387131-22-000582
- Form Type:
- 13D Filing
- Publication Date:
- 2022-01-20 19:00:00
- Filed By:
- Atlas Venture Fund Xii, L.p.
- Company:
- Vigil Neuroscience Inc.
- Filing Date:
- 2022-01-21
- SEC Url:
- 13D Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| ATLAS VENTURE FUND XII | 0 | 4,808,896 | 0 | 4,808,896 | 4,808,896 | 17.0% |
| ATLAS VENTURE ASSOCIATES XII | 0 | 4,808,896 | 0 | 4,808,896 | 4,808,896 | 17.0% |
| Atlas Venture Associates XII | 0 | 4,808,896 | 0 | 4,808,896 | 4,808,896 | 17.0% |
| Atlas Venture Opportunity Fund I | 0 | 1,027,978 | 0 | 1,027,978 | 1,027,978 | 3.6% |
| Atlas Venture Associates Opportunity I | 0 | 1,027,978 | 0 | 1,027,978 | 1,027,978 | 3.6% |
| Atlas Venture Associates Opportunity I | 0 | 1,027,978 | 0 | 1,027,978 | 1,027,978 | 3.6% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
VIGIL NEUROSCIENCE, INC.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
92673K108
(CUSIP Number)
Atlas Venture
Attention: Ommer Chohan, Chief Financial Officer
400 Technology Square, 10th Floor
Cambridge, MA 02139 USA
(857) 201-2700
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
January 11, 2022
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.